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Volume 6Available online 6 February 2021Background: Women represent an increasing proportion of the oncology workforce; however, globally this does not
translate into leadership roles, reflecting disparities in career opportunities between men and women. The Spanish
Society of Medical Oncology (SEOM) undertook a survey to investigate gender disparity in the Spanish oncology
context.
Design: An online survey was made available to SEOM medical oncologists between February and May 2019. It included
demographics, professional context and achievements, parenthood and family conciliation issues, workplace gender
bias, and approaches to address disparities.
Results: Of the 316 eligible respondents, 71.5% were women, 59.5% were aged 45 or younger, and 66.1% had children.
Among women, 12.4% were division or unit heads, compared with 45.5% of men, with most women (74.3%) being
attending medical oncologists, compared with 45.5% of men. More males were professors (34.4% versus 14.2% of
females), had a PhD (46.7% versus 28.8%), and/or had led clinical research groups (41.1% versus 9.7%). Spending
time overseas after completing a residency was also more common for men than women (34.4% versus 20.4%).
Professional satisfaction was similar between genders, driven primarily by patient care and intellectual stimulation.
More women (40.7%) considered parenthood to have a strong negative impact on their career, compared with men
(9.0%). Main perceived barriers to gender equality included a lack of workelife balance (72.6% women, 44.4%
men), bias of peers and superiors (50.0% women, 18.9% men), and different career goals (41.2% women, 24.4%
men). Preferred solutions included educational programs and scholarships (52.9%), communication and leadership
training (35.8%), childcare at conferences (33.2%), and postmaternity return-to-work incentives (32.0%).
Conclusion: There is a clear paucity of equal opportunities for female oncologists in Spain. This can be addressed by
encouraging professional development and merit recognition particularly for younger female oncologists, and
empowering women to be involved in management and leadership of institutions and professional societies.
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The subject of the gender gap in the professional context is
increasingly the focus of attention worldwide. While there
has been notable progress in reducing this gap over the past
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- Issue 2 - 2021challenges confronting females in the health and science
workplace in terms of equal opportunities in a variety of
cultural contexts. Women account for approximately two-
thirds of all workers in the health care area,1 and this
trend is continuing. In Spain, 2019 membership data of the
Spanish Society of Medical Oncology (SEOM) showed a
higher proportion of female oncologists (59%). This pre-
dominance is increasingly pronounced in younger age
brackets. In a survey of female and male oncologists per-
formed by the European Society for Medical Oncology
(ESMO) Women for Oncology (W4O) Committee in 2016,https://doi.org/10.1016/j.esmoop.2021.100048 1
ESMO Open E. Elez et al.67% of responding females were aged under 45.2 A similar
trend is apparent in the SEOM, with female members ac-
counting for nearly three-quarters of medical oncologists
aged 35 and younger in 2019.3
While globally women occupy a large proportion of po-
sitions within the oncology field, this does not translate into
an equivalent presence in senior and leadership roles in
academic or clinical settings, in either the public or the
private domain. This disparity is both deep seated and
multifactorial, and is seen in a variety of settings. Women
are underrepresented as presenters at major oncology
conferences, a recognized platform for breakthrough clinical
research. An analysis covering nearly a decade of annual
meetings of the American Society of Clinical Oncology
(ASCO) and ESMO showed that only 21% of oral pre-
sentations were by women, that women represented 28%
of all abstract authors, and that the proportion of female
presenters has not changed significantly over this period.4
Similarly, fewer women are recipients of prestigious re-
wards in the scientific and medical settings.5 Female
participation at an educative level in oncology training
programs and grand rounds seminars is also weaker, and is
particularly pronounced at the leadership level.6,7 With the
proportion of female oncologists continuing to increase, it is
essential that gender disparities be addressed.
A number of surveys over the last few years have re-
ported on the underrepresentation of women oncologists in
leadership roles worldwide, as well as women's perception
of the role of gender in their professional environment.2,8-11
Cultural factors can be strong gender drivers in the pro-
fessional environment, with women experiencing different
challenges and playing different roles in the workplace ac-
cording to the cultural setting. To better understand the role
of gender in professional satisfaction and career develop-
ment in the oncology field in the Spanish context, the SEOM
Working Group of Women in Oncology developed a ques-
tionnaire for its members, both male and female, focusing
on the perceptions of gender issues in the professional
context and what can potentially be done to address any
imbalances.MATERIALS AND METHODS
All SEOM members were invited to complete the ques-
tionnaire. To be eligible, participants had to be an SEOM
member and a medical oncologist, either qualified or in
training. The questionnaire was developed by the SEOM's
New Working Group of Women in Oncology, and was
adapted from the ESMO survey.2 Responses were anony-
mous. It consisted of 39 questions in Spanish, addressing
demographics, professional context, professional achieve-
ments, parenthood, and gender impact in the workplace,
and possible approaches to address these (see
Supplementary Information, available at https://doi.org/
10.1016/j.esmoop.2021.100048). Questions had pre-
specified multiple-choice answers, and for some questions
more than one answer and/or open text was possible.2 https://doi.org/10.1016/j.esmoop.2021.100048The survey was available online from February to May
2019. SEOM members were informed via the weekly elec-
tronic newsletter and a personalized email sent mid-way
during the survey availability period. A link to the survey
was also promoted on the SEOM website. The survey was
hosted on the SEOM website, and respondents could
complete it online at the time and location of their choice.
Participants were informed that the survey was voluntary
and that data were being collected anonymously. All data
were automatically collected and downloaded into MS Excel
(2010).
A descriptive analysis of study variables was performed.
Categorical variables were expressed as absolute values and
percentages. Fisher's exact test was used to compare the
percentage of responses across gender. Multivariate anal-
ysis was not conducted and no correction for multiple
testing was performed due to the exploratory nature of the
study. The data analyses were carried out using R statistical
software package version 3.6.2 (The R Foundation).RESULTS
Population demographics
Responses were collected from 318 of the 2151 members
contacted, two of whom were ineligible (not medical on-
cologists). Members from all 17 Spanish autonomous
communities responded, with the regions of Madrid, Cat-
alonia, Valencia, and Andalusia being the most highly rep-
resented, together accounting for 58.2% of respondents.
Other regions each represented between 1.0% and 6.7% of
the analyzed population.
Demographics are presented in Table 1. Among the 316
respondents, 226 (71.5%) were women and 90 (28.5%) were
men. Respondents were aged between 27 and 70, with 59.5%
aged 45 or younger. All professionally active age groups were
well represented. In terms of marital status, the majority of
respondents (76.9%) were married or living as a couple, and
66.1% of the population had children, with half of the cohort
having either one or two children. A higher proportion of
female respondents had no children compared with male
respondents (38.5% versus 24.4%, P ¼ 0.02).Professional environment
The large majority of respondents (95%) worked in a public
hospital with only 5% in private institutions. Most re-
spondents' institutions (n ¼ 230; 72.8%) had between 5 and
20 attending medical oncologists, with 5.7% (18 re-
spondents) working in large institutions (>30 attending
medical oncologists). More than half of the 316 re-
spondents (n ¼ 187; 59.2%) had a permanent contract.
Two-thirds (66.1%) of respondents were attending med-
ical oncologists (Table 1). The remainder mostly held senior
positions including 12.7% who were heads of division and
9.2% who were unit heads. The distribution of roles differed
between males and females, with the majority of women
(74.3%) holding positions as attending medical oncologists
versus 45.5% of males in the same position. By contrast,Volume 6 - Issue 2 - 2021











Female 226 (71.5) d d
Age (years)
30 35 (11.7) 29 (12.8) 6 (6.7)
31-40 110 (34.8) 90 (39.8) 20 (22.2)
41-50 88 (27.8) 66 (29.2) 22 (24.4)
51-65 76 (24.1) 38 (16.8) 38 (42.2)
>65 7 (2.2) 3 (1.3) 4 (4.4)
Marital status
Married/partner 244 (77.2) 166 (73.4) 78 (86.7)
Single 57 (18.0) 51 (22.6) 6 (6.7)
Separated/divorced/widowed 15 (4.7) 9 (4.0) 6 (6.7)
Number of children
0 109 (34.5) 87 (38.5) 22 (24.4)
1 47 (14.9) 36 (15.9) 11 (12.2)
2 113 (35.7) 74 (32.7) 39 (43.3)
3-5 47 (14.9) 29 (12.8) 18 (20.0)
Institution position
Attending medical oncologist 209 (66.1) 168 (74.3) 41 (45.5)
Department head 40 (12.7) 16 (7.1) 24 (26.7)
Resident/postgraduate 36 (11.4) 28 (12.4) 8 (8.9)
Unit head 29 (9.2) 12 (5.3) 17 (18.9)
Fellow 2 (0.6) 2 (0.9) 0
Management roles
PI of a competitively
funded research project
156 (49.4) 97 (42.92) 59 (65.5)
Leader of a research group 59 (18.7) 22 (9.7) 37 (41.1)
Leader of a cooperative group 29 (9.2) 12 (5.3) 17 (18.9)
Academic qualifications
Professorship 63 (19.9) 31 (13.7) 31 (34.4)
Medical degree 107 (33.9) 65 (28.8) 42 (46.7)
Doctoral thesisa 90 (28.5) 70 (31.0) 20 (22.2)
PI, principal investigator.
a Completed/ongoing.
E. Elez et al. ESMO Open12.4% of female respondents were division or unit heads,
compared with 45.6% of males (P < 0.001). These gender
differences were mirrored when respondents were




























Figure 1. Activities contributing to professional satisfaction (choice of 3 from a pr
Volume 6 - Issue 2 - 2021institution, reporting that within their institutions, 60.6%
(2031/3349) of attending physicians and 63.7% (1167/1831)
of fellows were women, whereas men accounted for 62.1%
of the unit heads (231/372) and 78.8% of the division heads
(249/316).Professional satisfaction and achievements
Three-quarters (n ¼ 241; 76.3%) of the respondents re-
ported being satisfied with their professional career, with a
slightly but not statistically significant higher proportion of
males (n ¼ 73; 81.1%) compared with females (n ¼ 168;
74.3%). When questioned over the aspects they most
enjoyed about their jobs from a prespecified list, their
relationship with patients was reported by almost all par-
ticipants (n ¼ 299; 94.6%), as was intellectual stimulus (n ¼
265; 83.9%; Figure 1). For most respondents (n ¼ 206;
65.2%), patient care accounted for at least three-quarters of
their time. Managing financial aspects was the least
appreciated part of their job (<1% of respondents). The
profiles of sources of potential satisfaction were similar
between males and females (P ¼ 0.34).
In terms of professional projects (Table 1), approximately
half of the respondents (49.4%) had led competitively
funded research projects, with a lower proportion of fe-
males receiving funding (42.9%) than males (65.6%; P <
0.001). Among the 160 remaining respondents, 128 (80.0%)
had never applied for a competitive grant, although 112
(70.0%) stated that they would like to lead projects, with
equivalent proportions of men and women. A total of 59
respondents (18.7% of the population) had led a clinical
research group during the last 5 years, corresponding to
41.1% (n ¼ 37) of males compared with 9.7% (n ¼ 22) of
females. Of note, for 42 (71.2%) of them, this role had not
been officially recognized. Most respondents (68.5%, 176/
257) who had not led a research group had not actively
















Women (n = 226)
Men (n = 90)
Total (n = 316)
especified list).
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ESMO Open E. Elez et al.patient care burden, lack of interest or of appropriate
qualifications, or hospital infrastructure. Only 9.2% (n ¼ 29)
had led a cooperative group, and the majority of those who
had not (269/287; 93.7%) had not actively applied to.
Overall, 33.9% (n ¼ 107) of respondents had a medical
degree, with a higher proportion of the male respondents
(46.7%, 42/90) than female respondents (28.8%, 65/226;
P < 0.01). Among respondents, 28.5% were working on or
had completed a doctoral thesis, corresponding to 22.2% of
males and 31.0% of females. In most cases (61.8%), re-
spondents cited a lack of time as the main reason for not
completing their thesis.
In terms of academic qualifications, 19.9% (63/316) of
participants were university professors, most of whom
(88.9%, 56/63) held associate professorships; among male
respondents, 34.4% (31/90) were professors compared with
14.2% of female respondents (32/226). Less than half the
participants (n ¼ 138, 43.7%) were aware of the Spanish
National Agency for Quality Assessment and Accreditation
(ANECA), and among them, most (n ¼ 113, 81.9%) had not
requested accreditation required for any academic position
at university. Seventy-seven respondents (24.4%) had spent
time overseas after completing a residency, most (n ¼ 61,
79.2%) of whom stayed for up to 12 months. This was more
common among male respondents (31/90, 34.4%) than
female respondents (46/226, 20.4%; P ¼ 0.01).Impact of parenthood and gender in the professional
context
Of the 201 parents who responded to the question whether
parenthood had negatively impacted their career, 40.7%
(55/135) of women considered that parenthood had a
strong negative impact on their professional career,
compared with 9.0% (6/66) of men (Figure 2A). Conversely
11.1% (15/135) of women considered there was no nega-
tive impact compared with 54.5% (36/66) of men.
In terms of gender impact on their careers, 68.9% (62/90)
of men considered it had no impact, compared with 15.9%
(36/226) of women. Most women (71.2%, 161/226) re-
ported a minor to moderate impact, compared with 22.2%
(20/90) of men (Figure 2B). From a prespecified list of the
main barriers to gender equality, lack of workelife balance
was the most common reason selected (64.6%, 204/316),
notably by women (72.6%, 164/226 versus 44.4%, 40/90;
P < 0.001) than men (Figure 2C). Bias of peers and supe-
riors (conscious or unconscious) was reported by 41.1%
(130/316) of respondents, chosen by 50.0% (113/226) of
women versus 18.9% (17/90) of men. Different career goals
were considered a barrier for 36.4% (115/316) of re-
spondents, selected by 41.2% (93/226) of women and
24.4% (22/90) of men. Men were more likely to consider
there were no barriers (38.9%, 35/90) compared with
women (4.9%, 11/226, P < 0.001). Lack of training was not
considered as a contributing reason by any of the re-
spondents. Among women, 41.6% (94/226) reported having
suffered sexist or pejorative comments compared with 4.4%
(4/90) of men. Inappropriate behavior in terms of gender or4 https://doi.org/10.1016/j.esmoop.2021.100048sexual orientation was also more frequently experienced by
women (28.8%, 65/226) than by men (13.3%, 12/90).
Participants were asked to select from a prespecified list
approaches they consider would support professional
development for female oncologists (Figure 3). Flexible
educational programs and scholarships ranked most highly
(52.9%, 167/316), along with skills training such as
communication and leadership (35.8%; 113/316), childcare
at conferences (33.2%, 101/316), and a financial incentive
to return to work after maternity leave (32.0%, 101/316).
The profile was similar for men and women, although
significantly more women than men saw value in education
programs (flexible education and scholarships 57.5% versus
41.1% of men; skills training 42.5% versus 18.9% of men, all
P values < 0.01).DISCUSSION
This SEOM survey offers insight into gender disparity in the
Spanish oncology setting. In our nationally representative
population, younger females dominated (2.5:1 female:male
ratio and 52.6% of female respondents were aged 40 or
younger, compared with 28.9% of male respondents), and
almost all respondents worked in public institutions with
moderate to large oncology services. In addition, although
we received 318 answers, this only represents nearly 15% of
the total population and is thus a potential limitation of the
study. The survey highlighted gender-based disparities in a
number of domains, with leadership and decision-making
positions dominated by men. Despite the fact that
women represent the majority of the oncology workforce,
significantly more male respondents held senior positions
compared with females (45.6% versus 12.4%, respectively),
and respondents confirmed this reflected the profiles of
their institutions. Similar gender disparities were apparent
in terms of professional achievements with four times as
many men as women having led a research group over the
last 5 years. In addition, obtaining competitive research
funding, leading cooperative groups, or achieving a pro-
fessorship were also notably more common among male
respondents, although these leadership roles were infre-
quent in the overall population.
These trends in poor representation of women in lead-
ership positions and academic achievements in this Spanish
cohort echo reports from other oncology settings and the
broader health care system. Recognition of this vertical
segregation is increasing, with calls to break this so-called
glass ceiling.12 Implicating women in leadership positions
provides a diverse perspective in a male-dominated medical
setting. Gender-diverse institutions are more likely to
outperform those that are not,13 whereas lower mortality
and hospital readmission rates have been reported with
female physicians.14
Men were more likely than women to consider that their
gender has not had any impact professionally (68.9% versus
15.9% respectively), whereas women primarily cited a mild
to moderate impact. The high proportion of younger female
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Lack of work–life balance [64.6%]
Colleague bias (conscious or not) [41.1%]
Different career goals [36.4%]
Lack of personal support [20.6%]
Social pressure [20.3%]
Lack ofconfidence in women's ability [19.6%]
No barriers [14.6%]
Lack of self-confidence (women) [12%]
Less defined career path [9.8%]
Lack of role models [9.2%]
Don't know [4.7%]




Figure 2. Impact of parenthood and gender. (A) Negative impact of parenthood on respondents' career (N [ 66 men; N [ 135 women); (B) Impact of gender on
respondents' career (N [ 90 men; N [ 226 women); (C) Three main barriers to gender equality, overall and by gender (N [ 90 men; N [ 226 women).
E. Elez et al. ESMO Openwith it being too early in younger participants' careers for a
true impact to have become apparent. Identifying perceived
barriers to gender inequality from both a male and female
perspective was revealing. While women were significantly
more likely to cite several factors than men, notably a lack
of workelife balance, peer bias, and different career goals,
men were primarily of the opinion that there were no
barriers to achieving gender equality. This is worth high-
lighting given the higher proportion of men in our cohort
who were themselves occupying leadership positions. This
lack of recognition of gender inequality by men and of theVolume 6 - Issue 2 - 2021barriers women face has been reported in the scientific
research setting.15
Perceived barriers reported in this Spanish female pop-
ulation, notably the challenges of balancing work and home
and unconscious biases (such as men being perceived as
natural leaders), echo those reported in other publications
addressing gender inequality in a range of populations,
including the ESMO survey, primarily reflecting a European
perspective (accounting for 72% of respondents),2 as well as
in the Middle East, North Africa, and India.10,16 Lack of
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Symbol ** represents P-values < 0.01 and ***  P-values < 0.001
Figure 3. Proposed approaches to addressing barriers to gender equality (men N [ 90; women N [ 226).
ESMO Open E. Elez et al.confidence were also cited as reasons, albeit less frequently,
across different geographic regions. A recent global study
reporting on barriers found they did not differ by age
group.17 Other factors such as difficulties in attending in-
ternational conferences or training programs, and lower
salaries were more prominently cited in surveys of female
oncologists in the Middle East, North Africa, and India.10,16
Among the two-thirds of participants who were parents,
women were four times as likely as men to report that
parenthood had a strong negative impact on their career
(40.7% versus 9.0%, respectively). Addressing workelife
balance in a social environment where women are
commonly expected to put family first highlights a need for
support in terms of shared responsibility for care of children
and aging parents. In a study investigating women leaving
surgical oncology, in addition to absence of interactions with
women, another important factor cited was unavailability of
or not having a valid reason for leave.18 Sexism and/or gender
discrimination in the workplace were reported by up to 40%
of our female respondents. Research has linked a harmful
workplace environment and gender-based discrimination
with adverse effects onwomen's occupationalwell-being and
health,19 and the unfavorable impact of these behaviors ap-
pears greater in male-dominated work contexts.20
In terms of scientific research, the gender gap is a
documented phenomenon that has had detrimental6 https://doi.org/10.1016/j.esmoop.2021.100048consequences, not only for women, but also for the quality
of research, suggesting that bias against female medical
oncologists might have consequences on research in
oncology. In addition, some research findings apply only to
men, establishing ‘biased knowledge’. Research into gender
bias is less likely to be funded and is published in journals
with a lower impact factors than research into equivalent
social discrimination such as race.21
The existing merit-based system is biased against gender
equality with the responsibilities of women outside of work
not taken into consideration such as when accessing funding.
The male-dominated professional and social systems
perpetuate this situation, penalizing women in the pursuit of
leadership positions, and contributing to maintaining the vi-
cious circle. Changes at the level of systems, organizations,
and policies have been advocated to address limitations
imposed by these networks on opportunities for women to
advance in their career path.17,22,23 Increasing transparency
of the system is an essential part of addressing this. Steps
need to be taken at the highest levels, with active encour-
agement and integration of diversity and inclusion into the
missions of institutions and oncology academic societies, as
highlighted by different organizations including SEOM and
ESMO.24 Academic societies should be role models demon-
strating leadership in advocating for gender equality.This can
include statements highlighting the absence of evidence forVolume 6 - Issue 2 - 2021
E. Elez et al. ESMO Opengender-based differences in science ability, ensuring inclusive
conferences in terms of speakers, expert panels, organizing
committees, and attendees, and implementing codes of
conduct to ensure equal financial support.22 Encouragingly,
one study noted that faculties with at least one woman in a
leadership position had a higher proportion ofwomen faculty
members, supporting a positive knock-on effect from
implementing change to reverse the current trends.7 The
reported presence ofwomen in senior leadership positions or
as invited speakers in national and international oncology
societies and conferences is dismally low (ranging from
approximately 10% to 25% depending on the position), with
similar outcomes in Europe and South America, and slightly
lower rates in Asia.25
At an institutional level, accountability and committed
resources (financial and infrastructure) are needed, such as
officially integrating dedicated time for gender-related
training and activities into staff workload, hiring adminis-
trative support staff, and formal recognition of contribu-
tions.22 In addition to appointing more women to senior
roles, other actions include seeking junior women for
mentorship and sponsorship, encouraging them to proac-
tively communicate their need for leadership, incentivizing
mentorship, and implementing targeted recruitment to
improve diversity.17 The current funding system undermines
the role of women. It has been reported that in the attri-
bution of health research funding, female principal in-
vestigators were evaluated less favorably than male
investigators, and this was not due to differences in the
quality of their proposals.26 The dominating position of men
in obtaining research funding is reproduced in authorship of
peer-reviewed publications, with a direct link established
between the proportion of female-first authorship and of
female faculty positions.27 Although the presence of
women in key author positions in oncology publications has
increased over time, efforts are required to significantly
improve current representation.28
Education about gender inequalities is a critical part of
the path forward, including integrating gender stereotypes
awareness and the value of diversity in improving outcomes
in science and medicine into curriculums at the under-
graduate and graduate levels.22 Girod et al. reported a study
implementing an educational program about gender bias
and strategies for reducing it within a medical faculty,
resulting in institutional change and promotion of women
to higher ranks.29 For young oncologists, the turning point
in their career is the end of residency. The significantly
higher proportion of males in our cohort who spent time
overseas after completing their residency (34.4% versus
20.4% of women) suggests that men can invest more time
at an early stage of their training, increasing their access to
senior professional opportunities, whereas for women
motherhood is a likely obstacle for traveling.
In our cohort, the high level of professional satisfaction
(over 75% of both men and women) was principally driven
by patient relationships and intellectual stimulation. How-
ever, participants primarily dedicated their time to patient
care, and therefore only limited time is available for theVolume 6 - Issue 2 - 2021development of additional professional skills, such as
leadership and management, or obtaining a PhD. Avail-
ability of educational programs and scholarships and skills
training for communication and leadership were supported
by a significantly higher proportion of women in our cohort
as means of improving their career opportunities, while
both men and women recommended childcare at confer-
ences and financial postmaternity return-to-work in-
centives. These are all widely reclaimed means of
addressing gender equality across geographical re-
gions.2,10,16 In a study by Riaz et al., while women in the
United States are clearly underrepresented in senior aca-
demic hematology and oncology positions (22% of full
professors, 36% of associate professors, and 45% of assis-
tant professors), after adjusting for clinical experience, ac-
ademic productivity, and workplace ranking, the odds of
obtaining professorship were not significantly different for
female and male physicians.30 This supports the theory that
for women to reach equal leadership representation, dif-
ferences in length of clinical experience need to be
addressed, and publication profiles and workplace visibility
must be increased.
Associations dedicated to promoting the role of women
in cancer care are an important foundation for the path to
changing current attitudes and habits, as well as an excel-
lent conduit for increasing awareness of career opportu-
nities for women. Several global groups have been formed,
such as the ESMO W4O Committee, the Women in
Oncology Work Group in ASCO, and Women in Cancer
Research (WICR) from AACR. National initiatives are being
launched, such as the Women's Working Group for
Oncology recently introduced by the SEOM,31 and the
ASEICA (Asociación Española de Investigación Sobre el
Cáncer/The Spanish Association for Cancer Research)
Mujer/Women, developed by the Spanish Association for
Cancer Research, which focuses on highlighting and
fostering the work of female cancer researchers in Spain.32
There are a number of possible biases inherent to this
study. Given the voluntary nature of the survey, it is likely
that SEOM members who feel more strongly that gender
disparity exists participated, potentially skewing the
outcome, as suggested by the participating population be-
ing more heavily weighted toward younger females. Ques-
tions establishing numbers within an institution may have
been affected if there was more than one respondent from
the same institution. The study was not planned to analyze
statistical associations between factors and responses, and
robust analyses in a larger sample size may be of interest.
The greater participation of younger female respondents
likely contributed to the lower proportion of females in
senior positions and with career achievements, whereas the
older male respondents could be expected to be at a more
advanced stage in their career. Nonetheless it is important
that such voices are heard, and the survey remains valid,
posing both objective and subjective questions.
Gender equality is not only just and fair, but implicit to the
value of a new leadership paradigm increasing diversity of
thought and of experience. It brings benefit not only tohttps://doi.org/10.1016/j.esmoop.2021.100048 7
ESMO Open E. Elez et al.marginalized groups that need to gain representation at the
table, but ultimately to the broader population who can also
benefit from new approaches toward long-standing, intrac-
table problems. Overall, in Spain, as elsewhere, there is a call
to shift the mechanics of addressing gender disparity from
individual behavior to comprehensive interventions including
education, affirmative action, and accountability, and to take
into account cultural specificities. The findings of this survey
will be used to support the career development of women in
Spain working in the oncology field, and to advocate for so-
cietal and cultural changes via public policies facilitating the
sharing of care responsibilities, as previously recom-
mended.33 Changing the status quo for female oncologists
requires their increased visibility and recognition, and an
active focus on appointing women to senior institutional and
committee positions, and as conference speakers, along with
increased access to funding and travel opportunities. Di-
versity and inclusion should be integrated into themissions of
professional oncology societies and the undergraduate edu-
cation courses. Changes to the social paradigm are an
important part of the foundations of addressing gender
inequality, andwill support changesmade to the professional
infrastructure.
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